Insero Health snags $1.1M to advance botanical huperzine for epilepsy
This article was originally published in Scrip
Executive Summary
Insero Health, a new company developing pharmaceuticals from natural products, has raised $1.1 million in its first round of financing, led by the Reich Group, based in Miami Beach, Florida. The startup, which is also based in Miami Beach, hopes to take its lead product huperzine into a Phase I/II trial in epilepsy later this year.